Package 0002-3182-61

{"route": ["SUBCUTANEOUS"], "spl_id": "1c705277-dd8e-46d0-86b0-2b57f47f5e5c", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["WTT295HSY5"], "rxcui": ["1551295", "1551300", "1551304", "1551306", "2395777", "2395779", "2395783", "2395785"], "spl_set_id": ["463050bd-2b1c-40f5-b3c3-0a04bb433309"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "2 SYRINGE in 1 CARTON (0002-3182-61)  / .5 mL in 1 SYRINGE", "package_ndc": "0002-3182-61", "marketing_start_date": "20200930"}, {"sample": false, "description": "4 SYRINGE in 1 CARTON (0002-3182-80)  / .5 mL in 1 SYRINGE (0002-3182-01)", "package_ndc": "0002-3182-80", "marketing_start_date": "20200903"}], "brand_name": "Trulicity", "product_id": "0002-3182_1c705277-dd8e-46d0-86b0-2b57f47f5e5c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0002-3182", "generic_name": "Dulaglutide", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trulicity", "active_ingredients": [{"name": "DULAGLUTIDE", "strength": "4.5 mg/.5mL"}], "application_number": "BLA125469", "marketing_category": "BLA", "marketing_start_date": "20200903", "listing_expiration_date": "20261231"}